<DOC>
	<DOCNO>NCT01617902</DOCNO>
	<brief_summary>This study aim evaluate incidence risk factor hyperbilirubinemia follow major cardiac thoracic aorta surgery , determine clinical impact hyperbilirubinemia postoperative mortality morbidity .</brief_summary>
	<brief_title>Hyperbilirubinemia After Cardiac Surgery</brief_title>
	<detailed_description>Patients receive elective cardiac thoracic aorta surgery monitor development postoperative hyperbilirubinemia . Collection data include patient baseline demographic characteristic , laboratory echocardiographic finding , procedural factor surgery , early postoperative variable . Serial postoperative liver function testing do hospitalization . Postoperative hyperbilirubinemia define serum bilirubin level 3mg/dL .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Hyperbilirubinemia</mesh_term>
	<criteria>Patients age 18 year schedule undergo elective major cardiac thoracic aorta surgery . Major cardiac surgery include coronary artery bypass grafting , pericardiectomy correction cardiac disease use cardiopulmonary bypassing ( valve surgery , tumor excision , arrhythmia surgery , heart transplantation , ventricular reconstruction , pulmonary thromboembolectomy , atrial ventricular septal defect closure ) . 1. univentricular oneandhalf ventricle repair 2. presence know liver cirrhosis hepatic cancer 3. history liver transplantation 4 . Genetic disease affect bilirubin metabolism ( i.e . Gilbert syndrome ) 5. preoperative bilirubin level 3mg/dL .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Hyperbilirubinemia</keyword>
	<keyword>cardiac</keyword>
	<keyword>surgery</keyword>
	<keyword>aorta</keyword>
	<keyword>prognosis</keyword>
</DOC>